Mylan Inc. (MYL) said its subsidiary Mylan Pharmaceuticals Inc. has launched Desloratadine Tablets, 5 mg, the generic version of Schering-Plough's Clarinex allergy medication.
Earlier, Mylan obtained final approval from the U.S. Food and Drug Administration, or FDA, for its Abbreviated New Drug Application for Desloratadine Tablets, 5 mg, and is shipping this product immediately.
According to IMS Health, Desloratadine Tablets, 5 mg, had U.S. sales of around $194.6 million for the 12 months ending March 31, 2012.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.